Latest news Back to 'Institute of Cardiovascular Sciences' Milestone moment for the region's life science sector as construction on No. 1 Birmingham Health Innovation Campus gets underway DescriptionConstruction of No.1 Birmingham Health Innovation Campus (BHIC) in Selly Oak is underway, marking a major milestone for the region's rapidly growing life sciences sector.Date:11/10/2021 Kidney donation does not increase the risk of cardiovascular disease for donors, research confirms DescriptionThe study has confirmed that donating a kidney does not have an adverse effect on a donor's cardiovascular system or blood pressure for at least five years.Date:21/09/2021 Artificial Intelligence approach helps to identify patients with heart failure that respond to beta-blocker treatment DescriptionResearchers at the University of Birmingham have developed a new way to identify which patients with heart failure will benefit from treatment with beta-blockers.Date:31/08/2021 Birmingham scientists discover new piece of clotting puzzle DescriptionIn research that provides a new perspective on how blood clotting works in infectious and inflammatory diseases, Birmingham scientists have described a potential new target and strategy for anti-thrombotic therapy.Date:25/08/2021 New research to find out what damage diabetes does to the smallest blood vessels of the heart in order to develop new therapies DescriptionDr Neena Kalia, Reader at the Institute of Cardiovascular Sciences, has been awarded a three-year BHF research grant to find out what damage diabetes does to the smallest blood vessels of the heart.Date:04/08/2021 New Birmingham-Roche collaboration targets new treatments for inflammatory bowel disease DescriptionA new £850k collaboration between Birmingham Health Partners and global biotechnology leaders Roche is set to improve both diagnosis and care of patients with inflammatory bowel disease.Date:04/08/2021 Partnership will create the next generation of researchers to transform global healthcare DescriptionThe Universities of Birmingham, Leicester and Nottingham have launched a partnership training the next generation of leading researchers the skills required to transform our understanding and treatment of disease.Date:13/07/2021 Launch of the national Congenital Heart Disease Priority Setting Partnership DescriptionToday, 29 June 2021, sees the launch of the UK's first national study to identify research priorities for children and adults diagnosed with congenital heart disease (CHD).Date:29/06/2021 Professor's success story used to mark BHF's 60th birthday celebrations DescriptionProfessor Paulus Kirchhof's success story of the the EAST-AFNET 4 clinical trial has been featured in the BHF's 60th birthday celebrations.Date:15/06/2021 University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb DescriptionThe University of Birmingham is part of a new industry collaboration launched to accelerate drug discovery projects that will fast track research from lab to patient.Date:06/05/2021 Displaying 1 to 10 of 78 Previous 1 2 3 4 5 … Next